NO20063809L - Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning - Google Patents
Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkningInfo
- Publication number
- NO20063809L NO20063809L NO20063809A NO20063809A NO20063809L NO 20063809 L NO20063809 L NO 20063809L NO 20063809 A NO20063809 A NO 20063809A NO 20063809 A NO20063809 A NO 20063809A NO 20063809 L NO20063809 L NO 20063809L
- Authority
- NO
- Norway
- Prior art keywords
- hydrochloride
- venlaflaxin
- mini tablets
- extended action
- coated mini
- Prior art date
Links
- 239000008185 minitablet Substances 0.000 title abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
- 238000013265 extended release Methods 0.000 abstract 2
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229960002416 venlafaxine hydrochloride Drugs 0.000 abstract 1
- QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Foreliggende oppfinnelse angår en farmasøytisk formulering med forlenget fiigjøring som taes en gang per dag, og omfatter venlafaxin hydroklorid og farmasøytisk akseptable eksipienter. Mer spesifikt angår foreliggende oppfinnelse en sammensetning med forlenget fiigjøring i form av minitabletter som er inkorporert i harde gelatin kapsler.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN117MU2004 | 2004-02-04 | ||
IN980MU2004 | 2004-09-13 | ||
PCT/IN2004/000340 WO2005074895A1 (en) | 2004-02-04 | 2004-10-27 | Extended release coated microtablets of venlafaxine hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20063809L true NO20063809L (no) | 2006-08-25 |
Family
ID=34809925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063809A NO20063809L (no) | 2004-02-04 | 2006-08-25 | Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning |
Country Status (24)
Country | Link |
---|---|
US (1) | US7807195B2 (no) |
EP (1) | EP1711169B1 (no) |
JP (1) | JP2007520547A (no) |
KR (1) | KR20070000439A (no) |
AT (1) | ATE361743T1 (no) |
AU (1) | AU2004315136B2 (no) |
BR (1) | BRPI0418283A (no) |
CA (1) | CA2555295C (no) |
CY (1) | CY1106741T1 (no) |
DE (1) | DE602004006443T2 (no) |
DK (1) | DK1711169T3 (no) |
ES (1) | ES2287813T3 (no) |
HK (1) | HK1091137A1 (no) |
HR (1) | HRP20070353T3 (no) |
IL (1) | IL177243A0 (no) |
MX (1) | MXPA06008854A (no) |
NO (1) | NO20063809L (no) |
NZ (1) | NZ548504A (no) |
PL (1) | PL1711169T3 (no) |
PT (1) | PT1711169E (no) |
RU (1) | RU2340331C2 (no) |
SI (1) | SI1711169T1 (no) |
UA (1) | UA82597C2 (no) |
WO (1) | WO2005074895A1 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL146462A (en) | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
PL377473A1 (pl) * | 2002-11-28 | 2006-02-06 | Themis Laboratories Private Limited | Sposób produkcji mikropeletek o przedłużonym uwalnianiu zawierających chlorowodorek wenlafaksyny |
WO2006136927A1 (en) * | 2005-06-22 | 2006-12-28 | Glenmark Pharmaceuticals Limited | Extended release formulations comprising venlafaxine |
EP1906935A4 (en) * | 2005-07-28 | 2010-10-20 | Reddys Lab Ltd Dr | VENLAFAXIN COMPOSITIONS WITH EXTENDED RELEASE |
US20090175934A1 (en) * | 2006-03-08 | 2009-07-09 | Jubilant Organosys Ltd. | Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same |
WO2007112574A1 (en) * | 2006-04-03 | 2007-10-11 | Isa Odidi | Extended release composition of venlafaxine |
EP2010162A4 (en) * | 2006-04-03 | 2013-01-09 | Isa Odidi | COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT |
WO2007129329A2 (en) * | 2006-05-08 | 2007-11-15 | Jubilant Organosys Limited | Extended release pharmaceutical formulation comprising venlafaxine hydrochloride |
EP2114455A4 (en) * | 2006-12-20 | 2010-03-17 | Mylan Pharmaceuticals Ulc | PHARMACEUTICAL COMPOSITION USING A HOT-MELT GRANULATED AGENT |
US20100179110A1 (en) * | 2006-12-20 | 2010-07-15 | Mostafa Akbarieh | Composition Containing a Bisphosphonic Acid in Combination with Vitamin D |
TWI391150B (zh) * | 2008-01-22 | 2013-04-01 | Taiwan Biotech Co Ltd | 腸溶性長效塗覆芯與藥物劑型及其製造方法 |
CN101756934A (zh) * | 2008-12-10 | 2010-06-30 | 上海复星普适医药科技有限公司 | 文拉法辛缓释制剂的制备方法 |
KR101787481B1 (ko) | 2010-10-21 | 2017-10-18 | 롯데정밀화학 주식회사 | 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐 |
WO2012104852A1 (en) | 2011-01-31 | 2012-08-09 | Serotech, Llc | Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder |
RU2733404C2 (ru) * | 2015-12-25 | 2020-10-01 | ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. | Таблетка, включающая 1-(3-(2-(1-бензотиофен-5-ил)этокси)пропил)азетидин-3-ол или его соли |
KR102062052B1 (ko) * | 2018-03-20 | 2020-01-03 | 일양약품주식회사 | 베타네콜 서방성 제제 및 이의 제조방법 |
KR20230067863A (ko) | 2021-11-10 | 2023-05-17 | 박찬호 | 스마트 계량도구 및 이를 이용한 요리보조 시스템 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4153677A (en) * | 1978-05-18 | 1979-05-08 | Sterling Drug Inc. | Controlled-release composition |
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US6440457B1 (en) | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
PE57198A1 (es) | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
UA77145C2 (en) | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
ID27724A (id) * | 1998-05-15 | 2001-04-26 | Warner Lambert Co | Penstabil sediaan parmasi dari turunan-turunan asam gamma-aminobutira dan proses pembuatannya |
KR100748913B1 (ko) | 1999-11-22 | 2007-08-13 | 알자 코포레이션 | 제 1 및 제 2 를 함유하는 삼투성 투약 형태 |
US6346269B1 (en) * | 2000-05-08 | 2002-02-12 | Standard Chem. & Pharm. Co., Ltd. | Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby |
US6350471B1 (en) * | 2000-05-31 | 2002-02-26 | Pharma Pass Llc | Tablet comprising a delayed release coating |
EP1385486A4 (en) * | 2001-04-18 | 2006-05-17 | Nostrum Pharmaceuticals Inc | NEW COATING OF SLOW RELEASE PHARMACEUTICAL COMPOSITION |
US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
CA2470636A1 (en) | 2001-12-20 | 2003-07-03 | Pharmacia Corporation | Zero-order sustained released dosage forms and method of making the same |
EP1474123A1 (en) * | 2002-01-03 | 2004-11-10 | LEK Pharmaceuticals D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
AR039164A1 (es) * | 2002-03-28 | 2005-02-09 | Synthon Bv | Sales de venlafaxina de baja solubilidad en agua |
AU2003226748A1 (en) * | 2002-03-28 | 2003-10-13 | Synthon B.V. | Compositions of venlafaxine base |
IL149055A0 (en) * | 2002-04-09 | 2002-11-10 | Karma Pharm Ltd | Extended release composition comprising as active compound venlafaxine hydrochloride |
CN1674877A (zh) * | 2002-06-07 | 2005-09-28 | 兰贝克赛实验室有限公司 | 控释的多单位药物释放*** |
US8216609B2 (en) * | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
US7058999B2 (en) * | 2002-10-24 | 2006-06-13 | Paramount Bed Co., Ltd. | Electric bed and control apparatus and control method therefor |
CA2503380A1 (en) * | 2002-10-25 | 2004-05-06 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions containing venlafaxine |
US6703044B1 (en) * | 2002-10-25 | 2004-03-09 | Dexcel Pharma Tech, Ltd | Venlafaxine formulations |
WO2004069228A2 (en) * | 2003-02-07 | 2004-08-19 | Omega Farma Ehf. | Sustained release formulations of venlafaxine |
PT1502587E (pt) * | 2003-07-30 | 2007-01-31 | Pharmathen Sa | Formulação de libertação prolongada para cloridrato de venlafaxina |
US7016014B2 (en) * | 2004-02-27 | 2006-03-21 | Asml Netherlands B.V | Lithographic apparatus and device manufacturing method |
-
2004
- 2004-10-27 WO PCT/IN2004/000340 patent/WO2005074895A1/en active IP Right Grant
- 2004-10-27 ES ES04821278T patent/ES2287813T3/es active Active
- 2004-10-27 JP JP2006552018A patent/JP2007520547A/ja active Pending
- 2004-10-27 AU AU2004315136A patent/AU2004315136B2/en not_active Ceased
- 2004-10-27 UA UAA200608949A patent/UA82597C2/uk unknown
- 2004-10-27 PT PT04821278T patent/PT1711169E/pt unknown
- 2004-10-27 EP EP04821278A patent/EP1711169B1/en active Active
- 2004-10-27 CA CA2555295A patent/CA2555295C/en not_active Expired - Fee Related
- 2004-10-27 RU RU2006129034/15A patent/RU2340331C2/ru not_active IP Right Cessation
- 2004-10-27 MX MXPA06008854A patent/MXPA06008854A/es active IP Right Grant
- 2004-10-27 DK DK04821278T patent/DK1711169T3/da active
- 2004-10-27 KR KR1020067014903A patent/KR20070000439A/ko not_active Application Discontinuation
- 2004-10-27 BR BRPI0418283-9A patent/BRPI0418283A/pt not_active IP Right Cessation
- 2004-10-27 SI SI200430372T patent/SI1711169T1/sl unknown
- 2004-10-27 NZ NZ548504A patent/NZ548504A/en unknown
- 2004-10-27 AT AT04821278T patent/ATE361743T1/de not_active IP Right Cessation
- 2004-10-27 DE DE602004006443T patent/DE602004006443T2/de not_active Expired - Fee Related
- 2004-10-27 PL PL04821278T patent/PL1711169T3/pl unknown
-
2005
- 2005-01-07 US US11/031,266 patent/US7807195B2/en not_active Expired - Fee Related
-
2006
- 2006-08-02 IL IL177243A patent/IL177243A0/en unknown
- 2006-08-25 NO NO20063809A patent/NO20063809L/no not_active Application Discontinuation
- 2006-11-20 HK HK06112748A patent/HK1091137A1/xx not_active IP Right Cessation
-
2007
- 2007-07-19 CY CY20071100959T patent/CY1106741T1/el unknown
- 2007-08-08 HR HR20070353T patent/HRP20070353T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES2287813T3 (es) | 2007-12-16 |
UA82597C2 (uk) | 2008-04-25 |
DK1711169T3 (da) | 2007-09-17 |
AU2004315136A1 (en) | 2005-08-18 |
CA2555295C (en) | 2011-01-18 |
US7807195B2 (en) | 2010-10-05 |
HRP20070353T3 (en) | 2008-01-31 |
US20050169985A1 (en) | 2005-08-04 |
KR20070000439A (ko) | 2007-01-02 |
EP1711169A1 (en) | 2006-10-18 |
BRPI0418283A (pt) | 2007-05-02 |
CA2555295A1 (en) | 2005-08-18 |
JP2007520547A (ja) | 2007-07-26 |
DE602004006443T2 (de) | 2008-01-10 |
PT1711169E (pt) | 2007-07-23 |
IL177243A0 (en) | 2006-12-10 |
RU2006129034A (ru) | 2008-03-10 |
HK1091137A1 (en) | 2007-01-12 |
NZ548504A (en) | 2009-03-31 |
AU2004315136B2 (en) | 2010-06-17 |
MXPA06008854A (es) | 2007-01-23 |
WO2005074895A1 (en) | 2005-08-18 |
ATE361743T1 (de) | 2007-06-15 |
DE602004006443D1 (de) | 2007-06-21 |
RU2340331C2 (ru) | 2008-12-10 |
PL1711169T3 (pl) | 2007-10-31 |
CY1106741T1 (el) | 2012-05-23 |
EP1711169B1 (en) | 2007-05-09 |
SI1711169T1 (sl) | 2007-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063809L (no) | Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning | |
AR116052A2 (es) | Forma cristalina de clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol | |
WO2008027557A3 (en) | Topiramate compositions and methods of enhancing its bioavailability | |
PE20050175A1 (es) | Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad | |
NO20100250L (no) | Farmasoytisk preparat som innbefatter en S1P reseptoragonist og en sukkeralkohol, og framgangsmate til fremstilling derav | |
AR049083A1 (es) | Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso | |
DK1792927T3 (da) | Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens | |
DE60330909D1 (de) | Tablette mit modifizierter freisetzung von bupropion hydrochlorid | |
ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
NO20084065L (no) | Hurtig frigivelses paracetamol tabletter | |
IL174830A0 (en) | Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation | |
NO20081038L (no) | Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering | |
ECSP045102A (es) | Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo | |
EA200970267A1 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ МНОЖЕСТВО МИНИ-ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР ФАКТОРА Xa | |
ECSP045409A (es) | Composiciones y metodos para dosificar liposomas de ciertos tamaños a fin de tratar o prevenir enfermedades. | |
PE20081106A1 (es) | Comprimidos pediatricos de capecitabina | |
UY25234A1 (es) | Formulación de liberación prolongada de venlafaxina | |
MY136136A (en) | Pharmaceutical compositions containing terbinafin and use thereof | |
NO20051261L (no) | Morfin-6-glukuronidsalt | |
PE20080313A1 (es) | Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas | |
ES2305567T3 (es) | Formulaciones de tramadol de liberacion sostenida con una eficacia de 24 horas. | |
CO6351711A2 (es) | Combinacion de dosis fija en la forma de una tableta de dos copas o de una sola capa de alisquireno y amlodipina | |
AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
AR067502A1 (es) | Pelets de administracion oral y liberacion retardada de clorhidrato de duloxetina | |
TNSN06242A1 (en) | Extended release coated minitablets of venlafaxine hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |